Article

Medicare now covers test for monitoring bladder cancer

Medicare groups in all but one state now cover the NMP22 BladderChek Test for both monitoring and diagnosis of bladder cancer, according to the test's manufacturer, Matritech.

Related Videos
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
DNA helix | Image Credit: © BillionPhotos.com - stock.adobe.com
Woman typing on laptop | Image Credit: © Gorodenkoff - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.